78364 Federal Register / Vol. 88, No. 219 / Wednesday, November 15, 2023 / Notices 

1More detailed information regarding this 

collection, including more detailed burden 

estimates, can be found in the OMB Supporting 

Statement posted at https://www.federalreserve.gov/ 

apps/reportingforms/home/review. On the page 

displayed at the link, you can find the OMB 

Supporting Statement by referencing the collection 

identifier, FR 28. 

FR 28a, the FR 28c requests additional 

information to make sure that conflicts 

of interest are fully vetted before an 

applicant is employed at the Board. 

The information collected through the 

FR 28 is used to assist the Board in 

recruiting and hiring individuals for 

Board employment, retaining qualified 

employees, and periodically reviewing 

its hiring practices. 

Frequency: Event-generated. 

Respondents: Individuals seeking 

employment with the Board. 

Total estimated number of 

respondents: 17,150. 

Total estimated annual burden hours: 

7,208.1

Board of Governors of the Federal Reserve 

System, November 8, 2023. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–25115 Filed 11–14–23; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–24–0666] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘National 

Healthcare Safety Network (NHSN)’’ to 

the Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on August 21, 2023 to obtain 

comments from the public and affected 

agencies. CDC received one comment 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

National Healthcare Safety Network 

(NHSN) (OMB Control No. 0920–0666, 

Exp. 6/30/2026)—Revision—National 

Center for Emerging and Zoonotic 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

The Division of Healthcare Quality 

Promotion (DHQP), National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC) collects 

data from healthcare facilities in the 

National Healthcare Safety Network 

(NHSN) under OMB Control Number 

0920–0666. During the early stages of its 

development, NHSN began as a 

voluntary surveillance system in 2005 

managed by DHQP. NHSN provides 

facilities, states, regions, and the nation 

with data necessary to identify problem 

areas, measure the progress of 

prevention efforts, and ultimately 

eliminate healthcare-associated 

infections (HAIs) nationwide. NHSN 

allows healthcare facilities to track 

blood safety errors and various HAI 

prevention practice methods such as 

healthcare personnel influenza vaccine 

status and corresponding infection 

control adherence rates. 

Enrollment in NHSN has 

continuously increased, with over 

37,000 actively reporting healthcare 

facilities across the U.S. Of the total 

enrolled healthcare facilities, there are 

over 6,000 acute care facilities; 8,400 

dialysis facilities; 600 long-term acute 

care facilities; 400 inpatient 

rehabilitation facilities; 800 inpatient 

psychiatric facilities; nearly 20,000 

long-term care facilities; and 6,000 

ambulatory surgery facilities. NHSN 

currently has eight components: Patient 

Safety (PS), Healthcare Personnel Safety 

(HPS), Biovigilance (BV), Long-Term 

Care Facility (LTCF), Outpatient 

Procedure (OPC), Dialysis Component, 

Neonatal Component, and Medication 

Safety Component. 

Data reported under the Patient Safety 

Component are used to determine the 

magnitude of the healthcare-associated 

adverse events and trends in the rates of 

the events, in the distribution of 

pathogens, and in the adherence to 

prevention practices. Data will help 

detect changes in the epidemiology of 

adverse events resulting from new 

medical therapies and changing patient 

risks. Additionally, reported data is 

being used to describe the epidemiology 

of antimicrobial use and resistance and 

to better understand the relationship of 

antimicrobial therapy to this rising 

problem. 

Under the Healthcare Personnel 

Safety Component, protocols and data 

on events—both positive and adverse— 

are used to determine: (1) the magnitude 

of adverse events in healthcare 

personnel; and (2) compliance with 

immunization and sharps injuries safety 

guidelines. 

Under the Biovigilance Component, 

data on adverse reactions and incidents 

associated with blood transfusions are 

reported and analyzed to provide 

national estimates of adverse reactions 

and incidents. 

Under the Long-Term Care Facility 

Component (LTCF), data is captured 

from skilled nursing facilities. Reporting 

methods under the LTCF component 

have been created by using forms from 

the PS Component as a model with 

modifications to specifically address the 

specific characteristics of LTCF 

residents and the unique data needs of 

these facilities reporting into NHSN. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 219 / Wednesday, November 15, 2023 / Notices 78365 

The Outpatient Procedure Component 

(OPC) gathers data on the impact of 

infections and outcomes related to 

operative procedures performed in 

Ambulatory Surgery Centers (ASCs). 

The OPC is used to monitor two event 

types: Same Day Outcome Measures and 

Surgical Site Infections (SSIs). 

The Dialysis Component offers a 

simplified user interface for dialysis 

users to streamline their data entry and 

analyses processes as well as provide 

options for expanding in the future to 

include dialysis surveillance in settings 

other than outpatient facilities. 

The Neonatal Component includes 

one module, Late-Onset Sepsis/ 

Meningitis (LOS/MEN). This module 

will track late-onset sepsis and 

meningitis events in very low 

birthweight neonates housed in Level II/ 

III, Level III, and Level IV nursery 

locations. 

The Medication Safety Component 

tracks medication safety and adverse 

drug events (ADEs) that are among the 

most common causes of iatrogenic harm 

in U.S. hospitals. 

NHSN has increasingly served as the 

operating system for HAI reporting 

compliance through legislation 

established by the states. As of March 

2019, 36 states, the District of Columbia 

and the City of Philadelphia, 

Pennsylvania have opted to use NHSN 

as their primary system for mandated 

reporting. Reporting compliance is 

completed by healthcare facilities in 

their respective jurisdictions, with 

emphasis on those states and 

municipalities acquiring varying 

consequences for failure to use NHSN. 

Additionally, healthcare facilities in five 

U.S. territories (Puerto Rico, American 

Samoa, the U.S. Virgin Islands, Guam, 

and the Northern Mariana Islands) are 

voluntarily reporting to NHSN. 

Additional territories are projected to 

follow with similar use of NHSN for 

reporting purposes. 

NHSN’s data is used to aid in the 

tracking of HAIs and guide infection 

prevention activities/practices that 

protect patients. The Centers for 

Medicare and Medicaid Services (CMS) 

and other payers use these data to 

determine incentives for performance at 

healthcare facilities across the US and 

surrounding territories, and members of 

the public may use some protected data 

to inform their selection among 

available providers. Each of these 

parties is dependent on the 

completeness and accuracy of the data. 

CDC and CMS work closely and are 

fully committed to ensuring complete 

and accurate reporting, which are 

critical for protecting patients and 

guiding national, state, and local 

prevention priorities. CMS collects 

some HAI data and healthcare personnel 

influenza vaccination summary data, 

which is done on a voluntary basis as 

part of its Fee-for-Service Medicare 

quality reporting programs, while others 

may report data required by a federal 

mandate. Facilities that fail to report 

quality measure data are subject to 

partial payment reduction in the 

applicable Medicare Fee-for-Service 

payment system. CMS links their 

quality reporting to payment for 

Medicare-eligible acute care hospitals, 

inpatient rehabilitation facilities, longterm acute care facilities, oncology 

hospitals, inpatient psychiatric 

facilities, dialysis facilities, and 

ambulatory surgery centers. Facilities 

report HAI data and healthcare 

personnel influenza vaccination 

summary data to CMS via NHSN as part 

of CMS’s quality reporting programs to 

receive full payment. Still, many 

healthcare facilities, even in states 

without HAI reporting legislation, 

submit limited HAI data to NHSN 

voluntarily. 

NHSN’s data collection updates 

continue to support the incentive 

programs managed by CMS. For 

example, survey questions support 

requirements for CMS’s quality 

reporting programs. Additionally, CDC 

has collaborated with CMS on a 

voluntary National Nursing Home 

Quality Collaborative, which focuses on 

recruiting nursing homes to report HAI 

data to NHSN and to retain their 

continued participation. The proposed 

changes in this new ICR include 

revisions to 23 existing data collection 

forms and nine new forms. In this 

Revision, CDC requests OMB approval 

for an estimated annual burden 

1,784,296 hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form number and name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. burden 

per response 

(min./hour 60) 

57.100 NHSN Registration Form ................................................................................................. 2,000 1 5/60 

57.101 Facility Contact Information ............................................................................................. 2,000 1 10/60 

57.103 Patient Safety Component—Annual Hospital Survey ..................................................... 5,311 1 135/60 

57.104 NHSN Facility Administrator Change Request Form ...................................................... 800 1 5/60 

57.105 Group Contact Information .............................................................................................. 1,000 1 5/60 

57.106 Patient Safety Monthly Reporting Plan ........................................................................... 7,821 12 15/60 

57.108 Primary Bloodstream Infection (BSI) ............................................................................... 5,775 5 39/60 

57.111 Pneumonia (PNEU) ......................................................................................................... 1,800 2 31/60 

57.112 Ventilator-Associated Event ............................................................................................ 5463 8 29/60 

57.113 Pediatric Ventilator-Associated Event (PedVAE) ............................................................ 334 1 31/60 

57.114 Urinary Tract Infection (UTI) ............................................................................................ 6000 5 21/60 

57.115 Custom Event .................................................................................................................. 600 91 36/60 

57.116 Denominators for Neonatal Intensive Care Unit (NICU) ................................................. 1,100 12 4/60 

57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC) ..................................... 500 12 5/60 

57.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA) .......... 5500 60 5/60 

57.120 Surgical Site Infection (SSI) ............................................................................................ 3,800 12 36/60 

57.121 Denominator for Procedure ............................................................................................. 3,800 12 10/60 

57.122 HAI Progress Report State Health Department Survey .................................................. 55 1 28/60 

57.123 Antimicrobial Use and Resistance (AUR)-Microbiology Data Electronic Upload Specification Tables .......................................................................................................................... 5,500 12 5/60 

57.124 Antimicrobial Use and Resistance (AUR)-Pharmacy Data Electronic Upload Specification Tables ................................................................................................................................ 5,500 12 5/60 

57.125 Central Line Insertion Practices Adherence Monitoring .................................................. 500 213 26/60 

57.126 MDRO or CDI Infection Form .......................................................................................... 720 11 31/60 

57.127 MDRO and CDI Prevention Process and Outcome Measures Monthly Monitoring ....... 5,500 29 15/60 

57.128 Laboratory-identified MDRO or CDI Event ...................................................................... 4800 79 21/60 


ddrumheller on DSK120RN23PROD with NOTICES1
78366 Federal Register / Vol. 88, No. 219 / Wednesday, November 15, 2023 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form number and name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. burden 

per response 

(min./hour 60) 

57.129 Adult Sepsis ..................................................................................................................... 50 250 25/60 

57.135 Late Onset Sepsis/Meningitis Denominator Form: Late Onset Sepsis/Meningitis Denominator Form: Data Table for monthly electronic upload .................................................... 300 6 5/60 

57.136 Late Onset Sepsis/Meningitis Event Form: Data Table for Monthly Electronic Upload 300 6 5/60 

57.137 Long-Term Care Facility Component—Annual Facility Survey ...................................... 17,700 1 120/60 

57.138 Laboratory-identified MDRO or CDI Event for LTCF ...................................................... 1,086 24 20/60 

57.139 MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF .............. 1,019 12 20/60 

57.140 Urinary Tract Infection (UTI) for LTCF ............................................................................ 339 36 35/60 

57.141 Monthly Reporting Plan for LTCF ................................................................................... 1,099 12 15/60 

57.142 Denominators for LTCF Locations .................................................................................. 714 12 35/60 

57.143 Prevention Process Measures Monthly Monitoring for LTCF ......................................... 357 12 5/60 

57.149 Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for LongTerm Care Facilities ................................................................................................................. 125 52 60/60 

57.150 LTAC Annual Survey ....................................................................................................... 392 1 89/60 

57.151 Rehab Annual Survey ..................................................................................................... 1,160 1 89/60 

57.200 Healthcare Personnel Safety Component Annual Facility Survey .................................. 50 1 480/60 

57.204 Healthcare Worker Demographic Data ........................................................................... 50 200 20/60 

57.205 Exposure to Blood/Body Fluids ....................................................................................... 50 50 60/60 

57.206 Healthcare Worker Prophylaxis/Treatment ..................................................................... 50 30 15/60 

57.207 Follow-Up Laboratory Testing ......................................................................................... 50 50 15/60 

57.210 Healthcare Worker Prophylaxis/Treatment-Influenza ...................................................... 50 50 10/60 

57.211 Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for NonLong-Term Care Facilities ........................................................................................................ 125 52 60/60 

57.214 Annual Healthcare Personnel Influenza Vaccination Summary ..................................... 5,000 1 120/60 

57.218 Weekly Resident Influenza Vaccination Cumulative Summary for Long-Term Care Facilities ........................................................................................................................................ 2,500 52 60/60 

57.300 Hemovigilance Module Annual Survey ........................................................................... 500 1 86/60

57.301 Hemovigilance Module Monthly Reporting Plan ............................................................. 500 12 60/60 

57.303 Hemovigilance Module Monthly Reporting Denominators .............................................. 500 12 77/60 

57.305 Hemovigilance Incident ................................................................................................... 500 10 10/60 

57.306 Hemovigilance Module Annual Survey—Non-acute care facility .................................... 500 1 36/60 

57.307 Hemovigilance Adverse Reaction—Acute Hemolytic Transfusion Reaction .................. 500 4 21/60 

57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction ................................. 500 4 21/60 

57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction .............. 500 1 21/60 

57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction ............... 500 2 21/60 

57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction ......... 500 4 21/60 

57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion Reaction ......................... 500 1 21/60 

57.313 Hemovigilance Adverse Reaction—Infection .................................................................. 500 1 21/60 

57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura ....................................... 500 1 21/60 

57.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea ........................... 500 1 20/60 

57.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease ..... 500 1 21/60 

57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury .................. 500 1 21/60 

57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload ........ 500 2 21/60 

57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction ............................. 500 1 21/60 

57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction ................................... 500 1 21/60 

57.400 Outpatient Procedure Component—Annual Facility Survey ........................................... 350 1 10/60 

57.401 Outpatient Procedure Component—Monthly Reporting Plan ......................................... 350 12 15/60 

57.402 Outpatient Procedure Component Same Day Outcome Measures ................................ 50 1 40/60 

57.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome 

Measures .................................................................................................................................. 50 400 40/60 

57.404 Outpatient Procedure Component—SSI Denominator ................................................... 300 100 10/60 

57.405 Outpatient Procedure Component—Surgical Site (SSI) Event ....................................... 300 36 35/60 

57.408 Monthly Survey Patient Days & Nurse Staffing .............................................................. 2500 12 60/60 

57.500 Outpatient Dialysis Center Practices Survey .................................................................. 7400 1 12/60 

57.501 Dialysis Monthly Reporting Plan ..................................................................................... 7400 12 5/60 

57.502 Dialysis Event .................................................................................................................. 7400 12 15/60 

57.503 Denominator for Outpatient Dialysis ............................................................................... 7400 24 10/60 

57.504 Prevention Process Measures Monthly Monitoring for Dialysis ...................................... 1730 12 75/60 

57.505 Dialysis Patient Influenza Vaccination ............................................................................ 615 50 10/60 

57.506 Dialysis Patient Influenza Vaccination Denominator ....................................................... 615 5 10/60 

57.507 Home Dialysis Center Practices Survey ......................................................................... 450 1 36/60 

57.130 New Form—Patient Safety Component FHIR Measure Respiratory Pathogens Surveillance (RPS)-IT Initial Set up ............................................................................................... 5,500 1 1620/60 

57.130 New Form—Patient Safety Component FHIR Measure Respiratory Pathogens Surveillance (RPS)-IT Yearly Maintenance ................................................................................... 5,500 1 1200/60 

57.130 New Form—Patient Safety Component FHIR Measure Respiratory Pathogens Surveillance (RPS)-Infection Preventionist .................................................................................... 5,500 1 6/60 

57.130 New Form—Patient Safety Component CSV Data Collection-Infection Preventionist 

CSV Data Collection-Infection Preventionist ........................................................................... 5500 365 2/60 

57.132 New Form—Patient Safety Component FHIR Measures-HOB, HT–CDI Modules-IT 

Initial Set up ............................................................................................................................. 5500 1 1620/60 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 219 / Wednesday, November 15, 2023 / Notices 78367 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form number and name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. burden 

per response 

(min./hour 60) 

57.132 New Form—Patient Safety Component FHIR Measures-HOB, HT–CDI Modules-IT 

Yearly Maintenance ................................................................................................................. 5500 1 1200/60 

57.132 New Form—Patient Safety Component FHIR Measures-HOB, HT–CDI Modules-Infection Preventionist ...................................................................................................................... 5500 6 6/60 

57.133 New Form—Patient Safety Component FHIR Measures-VTE Module-IT Initial Set up 5500 1 1620/60 

57.133 New Form—Patient Safety Component FHIR Measures-VTE Module-IT Yearly Maintenance ..................................................................................................................................... 5500 1 1200/60 

57.133 New Form—Patient Safety Component FHIR Measures-VTE Module- Infection 

Preventionist ............................................................................................................................. 5500 6 6/60 

57.600 New Form—Neonatal Component FHIR Measure-Late Onset Sepsis Meningitis 

(LOSMEN) Module-IT Initial Set up ......................................................................................... 5500 1 1620/60 

57.600 New Form—Neonatal Component FHIR Measure-Late Onset Sepsis Meningitis 

(LOSMEN) Module-IT Yearly Maintenance ............................................................................. 5500 1 1200/60 

57.600 New Form—Neonatal Component FHIR Measure-Late Onset Sepsis Meningitis 

(LOSMEN) Module-Infection Preventionist .............................................................................. 5500 6 6/60 

57.600 New Form—Neonatal Component Late Onset Sepsis Meningitis (LOSMEN) Module 

CDA Data Collection-Infection Preventionist ........................................................................... 5500 12 2/60 

57.700 New Form—Medication Safety Component FHIR Measure-Glycemic Control Module 

Hypoglycemia-IT Initial Set up ................................................................................................. 5500 1 1620/60 

57.700 New Form—Medication Safety Component FHIR Measure-Glycemic Control Module 

Hypoglycemia-IT Yearly Maintenance ..................................................................................... 5500 1 1200/60 

57.700 New Form—Medication Safety Component FHIR Measure-Glycemic Control Module 

Hypoglycemia-Infection Preventionist ...................................................................................... 5500 6 6/60 

57.701 New Form—Glycemic Control Module-HYPO Annual Survey ........................................ 10 1 120/60 

57.144 New Form—Long Term Care Respiratory Tract Infections (RTI) Module ...................... 16,500 24 25/60 

57.145 New Form—Long Term Care Antimicrobial Use (LTC–AU) Module CDA ..................... 16,500 12 5/60 

New Form—Billing Code Data: 837I Upload ............................................................................... 5500 4 5/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–25156 Filed 11–14–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

In accordance with 5 U.S.C. 1009(d), 

the Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, CDC, pursuant to Public Law 

92–463. 

Name of Committee: Safety and 

Occupational Health Study Section 

(SOHSS), National Institute for 

Occupational Safety and Health 

(NIOSH). 

Dates: February 6–7, 2024. 

Times: 11 a.m.–5 p.m., EST. 

Place: Teleconference. 

Agenda: The meeting will convene to 

address matters related to the conduct of 

Study Section business and for the 

Study Section to consider safety and 

occupational health-related grant 

applications. 

For Further Information Contact: 

Michael Goldcamp, Ph.D., Scientific 

Review Officer, Office of Extramural 

Programs, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention, 

1095 Willowdale Road, Morgantown, 

West Virginia 26506. Telephone: (304) 

285–5951; Email: MGoldcamp@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–25120 Filed 11–14–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10662] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 


ddrumheller on DSK120RN23PROD with NOTICES1